S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

SCI Pharmtech Inc
Gross Profit Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Gross Profit
NT$347.4m
CAGR 3-Years
-19%
CAGR 5-Years
-17%
CAGR 10-Years
-3%
Y
YungShin Global Holding Corp
TWSE:3705
Gross Profit
NT$3.2B
CAGR 3-Years
-4%
CAGR 5-Years
-2%
CAGR 10-Years
3%
Formosa Laboratories Inc
TWSE:4746
Gross Profit
NT$2.1B
CAGR 3-Years
28%
CAGR 5-Years
22%
CAGR 10-Years
12%
ScinoPharm Taiwan Ltd
TWSE:1789
Gross Profit
NT$1.3B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
-4%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Gross Profit
NT$9.3B
CAGR 3-Years
19%
CAGR 5-Years
20%
CAGR 10-Years
22%
Standard Chem & Pharm Co Ltd
TWSE:1720
Gross Profit
NT$2.9B
CAGR 3-Years
14%
CAGR 5-Years
12%
CAGR 10-Years
8%

See Also

What is SCI Pharmtech Inc's Gross Profit?
Gross Profit
347.4m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Gross Profit amounts to 347.4m TWD.

What is SCI Pharmtech Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
-3%

Over the last year, the Gross Profit growth was -8%. The average annual Gross Profit growth rates for SCI Pharmtech Inc have been -19% over the past three years , -17% over the past five years , and -3% over the past ten years .

Back to Top